A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

Overview of attention for article published in Investigational New Drugs, October 2006

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 51 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

Grant US-8999934-B2

United States of America